Embla Medical
| Date: | 30.7.2026 |
|---|---|
| Country: | Iceland |
| Customer: | Embla Medical |
| Amount in EUR: | EUR 50 million |
| Maturity: | 7 years |
| Business sector: | Connectivity & Consumer |
Project
The loan has been provided to Embla Medical hf. to finance its research and development activities during 2027–2029. The activities focus on the development of innovative prosthetics, orthotics and mobility solutions, supported by a global research and development network.
Total project costs are estimated to be approximately EUR 145 million.
Fulfilment of NIB's mandate
The project contributes to productivity by supporting research, development and innovation in the medical technology sector. Continued investment in innovation is essential to maintaining competitiveness and advancing healthcare solutions. Collaboration with healthcare institutions and partners contributes to knowledge development and productivity.
Sustainability summary
The project is in line with the Bank’s sustainability policy and guidelines, and no significant sustainability concerns have been identified.
